Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Abbott Laboratories’ ABT Diabetes Care business has become one of its most dynamic growth engines, driven primarily by its FreeStyle Libre continuous glucose monitoring (CGM) platform. In a relatively ...

Abbott Laboratories is reshaping the investment landscape with its latest trading strategies. Mid-range consolidation at $130 ...

Abbott Laboratories is gearing up for a potentially lucrative market play. Mid-term corrections in a long-term uptrend are ...

However, state troopers may have limited ability to enforce Abbott's order. Under House rules, the Texas House can authorize ...

High-quality dividend stocks can provide superior returns and consistent passive income over the long term. The two companies below are leaders in their respective industries and boast attractive ...

Looking for the latest stock opportunities in August 2025? Click to read these top stock picks to consider adding to your portfolio now.

Abbott Laboratories (NYSE:ABT) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty.

CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced ...

Dividend growth rates over a 5-year or longer period can be a good indicator of strong growth potential in picking a stock ...

Abbott Laboratories (NYSE: ABT) is one of the top low volatility healthcare stocks to buy now. Analyst Mike Kratky from ...

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 5.8% over the past month. However, a closer look at its sound financials ...